How much funding has NextCure raised?

NextCure has raised $160.0M in total funding, most recently a series b round.

Who are NextCure's investors?

NextCure's investors include Canaan Partners, Hillhouse Capital, Lilly Asia Ventures, OrbiMed, Pfizer Ventures, Sofinnova Investments.

Where is NextCure headquartered?

NextCure is headquartered in Beltsville, Maryland, United States.

NextCure

IPO

NextCure, Inc.

Beltsville, United States · Founded 2015 · $160.0M raised

Biotech

Headquarters: Beltsville, Maryland
Employees: 51–200
Founded: 2015
Business Model: B2B

Website: nextcure.com
Total Funding: $160.0M
Last Round: $93.0M Series BNov 2018
Rounds: 2

About

NextCure is a clinical-stage biopharmaceutical company developing novel immunomedicines to treat cancer and immune-related diseases. Founded in 2015, the company leverages its FIND-IO technology platform to discover and develop first-in-class medicines targeting immune pathways. Headquartered in Beltsville, Maryland, NextCure trades on Nasdaq under the ticker NXTC.

Summary

NextCure is a Biotech company based in Beltsville, United States, founded in 2015. It has raised $160.0M in total across 2 rounds, most recently a $93.0M Series B round in Nov 2018. Investors include Canaan Partners, Hillhouse Capital and Lilly Asia Ventures.